B. Liemberger

RNA Trans-Splicing Modulation via Antisense Molecule Interference

J. Reichelt, T. Kocher, J. Bauer, 2018, International journal of molecular sciences.

COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa

D. Strunk, J. Reichelt, J. Bischof, 2022, Frontiers in Medicine.

A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa

D. Strunk, T. Cathomen, J. Bischof, 2021, Molecular therapy. Nucleic acids.

Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa

J. Lambert, T. Lettner, A. Klausegger, 2021, International journal of molecular sciences.

COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents

J. Bischof, T. Kocher, J. Bauer, 2023, International journal of molecular sciences.

Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis Bullosa.

D. Strunk, J. Bischof, A. Klausegger, 2020, The Journal of investigative dermatology.

A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa

D. Strunk, J. Bischof, T. Kocher, 2023, International journal of molecular sciences.

Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studies

C. Gretzmeier, T. Kocher, A. Nyström, 2019, Matrix biology plus.

Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa

A. Klausegger, T. Kocher, C. Guttmann-Gruber, 2024, International journal of molecular sciences.